Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of anti-human csf-1r monoclonal antibody and its application

A technology of CSF-1R and monoclonal antibody, applied in the fields of antibody, application, anti-animal/human immunoglobulin, etc., can solve problems that need further research and development, and achieve the effect of novel sequence

Active Publication Date: 2019-04-16
BIOSION INC
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Although CSF1R antibodies have been developed, CSF1R inhibitors with higher affinity and other key properties of drugs for the treatment of the above diseases, especially monoclonal antibodies, still need to be further researched and developed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of anti-human csf-1r monoclonal antibody and its application
  • A kind of anti-human csf-1r monoclonal antibody and its application
  • A kind of anti-human csf-1r monoclonal antibody and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Embodiment 1 obtains the mouse monoclonal antibody of specific anti-CSF1R by fusion hybridoma technology

[0036] 1.1 Animal immunity

[0037] Mice were immunized according to the general method in the literature (E Harlow, D. Lane, Antibody: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., 1998). The immunogen is a recombinant human CSF1R (amino acid interval I l e20-Glu 512) protein (Acrobiosystems, Cat#CSR-H5258) containing a human IgG1Fc tag at the C-terminus. Recombinant human CSF1R protein with his s tag (Acro biosystems, cat#CSR-H5228) was used as the detection antigen for determination of serum titer and hybridoma screening. Briefly, remove an appropriate amount of Freund's adjuvant into a 1.5ml EP tube, and shake to mix. Prepare the antigenic protein solution with PBS. Mix the adjuvant and protein antigen solution according to the required amount, fully emulsify the antigen by pushing each other through the syringe to form ...

Embodiment 2

[0043] Example 2 In vitro assay method for measuring CSF1R monoclonal antibody functional activity

[0044] 2.1 Determination of antibody binding ability based on capture ELSIA Prepare goat anti-mouse IgG Fcr-specific secondary antibody (Jackson Immuno Research, #115-006-071) with 1xPBS, so that the final concentration is 2 μg / ml, add liquid at 100 μl / well In 96-well ELISA plate, coated overnight at 4 degrees. The next day, after washing the plate 4 times with PBS solution containing 0.05% Tween 20 (ie 1xPBST), 200 μl / well of 5% skim milk powder in PBST solution was added and placed at 37°C for 2 hours to block. Wash the plate again, add 100 μl / well of diluted antibody solution or hybridoma supernatant, incubate at 37 degrees for 40 minutes, and then wash the plate 4 times. Add the prepared 60 nM biotin-labeled human CSF1R Fc protein solution (in 2.5% skimmed milk powder in PBST) at 100 μl / well, incubate at 37°C for 40 minutes, and then wash the plate 4 times. Add 1:10000 di...

Embodiment 3

[0053] Example 3 Binding activity of anti-CSF1R mouse monoclonal antibody

[0054] According to the analysis method described in Example 2, the evaluation of the binding activity of the CSF1R antibody is summarized in Table 2 below. Among them, Benchmark (Cabiralizumab) is used as a control, which is an existing non-commercialized anti-human CSF1R monoclonal antibody. It can be seen from Table 2 that the binding activity of the anti-human CSF-1R monoclonal antibody of the present invention to human CSF1R antigen is significantly better than that of Benchmark.

[0055] Table 2 Binding activity of CSF1R antibody

[0056]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an anti-human CSF-1R monoclonal antibody and use thereof, and provides an encoding nucleic acid molecule, an expression vector, a host cell for the antibody and a method for expressing the antibody. Antibody immunoconjugate conjugates comprising the antibody, bispecific molecules, chimeric antigen receptors, pharmaceutical compositions, and use are also provided. Comparedwith the prior art, the anti-human CSF-1R monoclonal antibody has the advantages that according to the monoclonal antibody that can specifically identify human CSF-1R, the antibody has stronger affinity for binding to the human CSF-1R than an existing anti-human CSF-1R monoclonal antibody, and a sequence of the antibody is novel.

Description

technical field [0001] The invention relates to a high-affinity and functional anti-human CSF1R monoclonal antibody or antibody fragment. The present invention also provides the encoding nucleic acid molecules of the antibody, expression vectors, host cells, and methods for expressing the antibody. Also provided are antibody immunoconjugates, bispecific molecules, chimeric antigen receptors, pharmaceutical compositions, and diagnostic and therapeutic methods comprising antibodies of the invention. Background technique [0002] Colony-stimulating factor 1 receptor (CSF-1R), which belongs to the type III receptor tyrosine kinase family, is encoded by the proto-oncogene c-fms. The ligand-binding domain of a protein-like structure. CS1R is expressed on the surface of mononuclear phagocytes and plays a key role in the survival, proliferation and differentiation of mononuclear phagocytes (Felix, et al., (2015) Structure 23, 1621-1631). And CSF1R is also highly expressed on the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K16/28C12N15/13A61K39/395A61P35/00A61P29/00A61P19/02A61P9/10A61P19/08
CPCA61K2039/505A61P9/10A61P19/02A61P19/08A61P29/00A61P35/00C07K16/2866C07K2317/565
Inventor 陈明久谭巍
Owner BIOSION INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com